ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

New Creatinine Test Raises Questions About Accuracy Of Carboplatin Dosing

October 8, 2010

President Requests Extra $200 Million For NIH

March 7, 2014

Bill Requires NIH-Funded Researchers To Send Manuscripts To PubMed Central.

November 2, 2007

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

August 30, 1974

NCI 1980s Challenge: Matching Schientific Priorities With Resources, DeVita Says At Swearing-In

August 15, 1980

In Brief; “Sense of Urgency” In Research Is Theme of New AACR President Daniel Von Hoff

April 16, 1999